NF-kB (k-hammer enhancement of nuclear factor-activated B cells) plays a key regulatory role in cytokine-induced gene expression, and it regulates genes encoding: acute phase response proteins, cytokines, cell adhesion molecules , immune regulatory molecules, viral oncogenes, growth factors, transcription and growth regulators, etc. By regulating the expression of various genes, NF-kB is involved in various biological processes such as immune response, inflammatory response, apoptosis, and tumorigenesis.
The NF-kB family consists of cRel, RelA (p65), RelB, NF-kB1 (p50), NF-kB2 (p52), and they all have Rel homology domains at the N-terminus, among which cReI, ReIA (p65) and ReIB has a transcription activation domain (TAD), which can positively regulate gene expression; p52 and p50 are cleaved from the precursor proteins p100 and p105, respectively, and the C-terminus of the precursor protein has a structure similar to NF-kB inhibitor (IκB) , as IkB-like proteins inhibit NF-kB function, and their homodimers can inhibit transcription.
Indicator name |
reactivity |
application |
NFκB p65 mAb(5G6) |
H.M.R |
WB.IHC-p.IF/ICC.IP |
NFκB-p65 pAb |
H.M.R |
WB.IHC-p.lF(P).IP.ELISA |
NFκB-p65 (Thr505) pAb |
H.M.R |
WB.IHC-p.lF(P).ELISA |
NFκB-p65 (Thr435) pAb |
H.MRMκ |
WB.IHC-p.IF(P).IP ELISA |
NFκB-p65 (Thr254) pAb |
H.M.R |
WB.IHC-p.lF(P).IP ELISA |
NFκB-p65 (Sec536) pAb |
H.M.R.Mκ |
IF/ICC.WB.IHC-p.IP.ELISA |
NFκB-p65 (Ser529) pAb |
H.M.R.Mκ |
IF/ICC.WB.IHC-p.ELISA |
NFκB-p65 (Ser468) pAb |
H.M.R |
WB.IHC-p.IF(P).IP ELISA |
NFκB-p65 (Ser311) pAb |
H.M |
WB.IHC-p.IF/ICC.ELISA |
NFκB-p65(Ser281)pAb |
H.M.R |
IHC-p.lF(P).ELISA |
NFκB-p65 (Ser276) pAb |
H.M.R |
WB.IHC-p.lF(P).lP.ELISA |
RelB (Ser552) pAb |
H.M |
WB.IHC-p.lF(P).ELISA |
RelB pAb |
H.M |
WB.ELISA |
c-Rel mAb |
H.M |
WB.IHC-p.IF/ICC.ELlSA |
c-Rel pAb |
H.R.M. |
WB.IHC-p.lF(P).ELISA |
c-Rel (Ser503) pAb |
H.R.M. |
WB.IHC-p.lF(P).ELISA |
NF-κB P105/P50 M mAb(4D11) |
H. M |
IHC-p.WB |
NFκB-p105/p50mAb |
H |
WB.IHC-p.IF/lCC.FCM.ELISA |
NFκB-p105/p50pAb |
H.M.R |
IF/ICC.WB.IHC-p.ELISA |
NFκB-p105/p50 (Ser337) pAb |
H.M.R |
WB.IHC-p.IF/ICC.ELISA |
NFκB-p105(Ser932)pAb |
H.M.R |
WB.IHC-p.lF(P).ELISA |
NFκB-p105(Ser927)pAb |
H.M |
WB.IHC-p.IF/ICC.ELISA |
NFκ0-p105 (Ser907) pAb |
H.R.M. |
WB.IHC-p.lF(P).IP.ELISA |
NFκB-p105 (Ser893) pAb |
H.R.M. |
WB.IHC-p.lF(P).ELISA |
NF-κB p105 (Ser923) rabbit pAb |
H.M |
WB. ELISA |
NF-κB p105 (Ser903) rabbit pAb |
H.M |
WB. ELISA |
NF-κB p105 (Cleaved-Thr434) rabbit pAb |
H.M |
WB. ELISA |
NF-κB p105 (Cleaved-Gly433) rabbit pAb |
H.M |
WB. ELISA |
NF-κB2 p100 (-Ser866/870) rabbit pAb |
H.M |
WB |
NFκB-p100 (Ser865) pAb |
H.M.R |
WB.IHC-p.IP.IF/lCC.ELISA |
NFκB-p100 (Ser869) pAb |
H.M.R |
WB.IHC-p.lF(P).IP.ELISA |
NFκB-p100 (Ser872) pAb |
H.M |
WB.ELISA |
NFκB-p100 pAb |
H.M.R |
WB.IHC-p.IP.IF/ICC.ELISA |
IKKα mAb |
H |
WB.IF/ICC.FCM.ELISA |
IKKα/β pAb |
H.M.R |
WB.IHC-p.IF(P).ELISA |
IKKα (Thr23) pAb |
H.M.R |
WB.IHC-p.lF(P).ELISA |
IKKα pAb |
H.M.R |
WB.IHC-p.lF(P).ELISA |
IKKα/β (Ser176/177) pAb |
H.M.R |
WB.IHC-p.IF(P).ELISA |
IKKα/β (Ser180/181) pAb |
H.M.R |
WB.IHC-p.lF(P).ELISA |
IKKβ pAb |
H.M.R |
WB.IHC-p.lF(P).ELlSA |
IKKβ mAb |
H |
WB.IHC-p.lF(P).ELISA |
IKKβ (lyr199) pAb |
H.M.R |
WB.IHC-p.IF(P).ELISA |
IKKβ (Tyr188) pAb |
H.M.R.Mκ |
WB.IHC-p.IF(P).ELISA |
IKKγ pAb |
H.M.R |
WB.IHC-p.lF(P).ELISA |
IKKγ (Ser85) pAb |
H.R.M. |
WB.IHC-p.IF(P).ELlSA |
IKKγ (Ser376) pAb |
H.R.M. |
IHC-p.IF(P).ELISA |
IKKγ (Ser31) pAb |
H.R.M. |
WB.IHC-p.lF(P).ELISA |
IκB α M mAb(2A5) |
H. M.R |
IHC-p.WB |
IκB-α pAb |
H.M.R |
WB.IHC-p.IF/lCC.ELISA |
IκBα (-Ser32) rabbit pAb |
H.M.R |
WB |
lκB-α (Tyr42) pAb |
H.M.R |
WB.IHC-p.lF(P).ELISA |
IκB-α (Tyr305) pAb |
H.M.R.Mκ |
WB.IHC-p.lF(P).ELISA |
IκB-α (Ser32/S36) pAb |
H.M.R.Mκ |
WB.IHC-p.IF/ICC.ELISA |
ELK Biotechnology® is located in the beautiful and rapidly developing city of Wuhan, Hubei Province. It is located in the national industrial base with modern medical services, medical equipment and biomedicine as the core - the Optics Valley Pharmaceutical Enterprise Accelerator in Donghu High-tech Zone.
ELK Biotechnology® is a high-tech biological company specializing in the R&D and production of immune and molecular biology products. Products cover ELISA kits, antibodies, genome extraction reagents, and molecular biology reagents. Involving immunochemistry, tumor research, neurobiology, cell cycle, signal transduction and other fields. Our products have strict R&D and quality inspection processes, complete quality inspection support departments, and strict inspection processes, providing customers with scientific research products with reliable quality. Since 2018, the company has developed markets at home and abroad, and we have reached stable cooperation with customers from 5 continents and more than 50 countries at home and abroad. High-quality products, perfect ordering, delivery and after-sales processes have won us customers' satisfaction. Trust and praise.